Revenue
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | €8.17B | €8.27B | €8.01B | €7.96B | €8.06B | €6.94B |
| Research & development | €181.4M | €183.7M | €175.1M | €164.6M | — | — |
| Operating expenses | €2.71B | €2.59B | €2.50B | €2.41B | — | — |
| Operating income | €502.1M | €540.0M | €667.5M | €547.0M | €714.8M | €503.3M |
| Operating margin | 6.15% | 6.53% | 8.34% | 6.87% | 8.87% | 7.25% |
| EBITDA | €784.4M | €834.9M | €961.5M | €821.3M | €986.8M | €777.2M |
| EBITDA margin | 9.60% | 10.10% | 12.01% | 10.32% | 12.24% | 11.20% |
| Net income | €282.7M | €282.7M | €439.4M | €368.3M | €507.6M | €348.7M |
| Net profit margin | 3.46% | 3.42% | 5.49% | 4.63% | 6.30% | 5.02% |
| Basic EPSper basic share | €4.47 | €4.26 | €7.01 | €5.74 | €8.42 | €6.00 |
| Diluted EPSper diluted share | €4.45 | €4.23 | €6.97 | €5.71 | €8.36 | €5.96 |